MTCP1 and B-cell chronic lymphocytic leukemia: Further interrogating this phenomenon we demonstrate the capacity for MTCP1  to initiate development of an aggressive murine CLL-like leukemia, revealing MTCP1 as a target for exploring the pathogenic mechanisms driving CLL.